EVN (OTCMKTS:EVNVY – Get Free Report) and H. Lundbeck A/S (OTCMKTS:HLUYY – Get Free Report) are both utilities companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, risk, valuation, analyst recommendations, institutional ownership and dividends. Analyst Ratings This is a summary of current […]
/PRNewswire/ Rgenta Therapeutics ("Rgenta" or the "Company") today announced that it was selected by The Leukemia & Lymphoma Society (LLS) as a new Therapy.
H. Lundbeck A/S (OTCMKTS:HLUYY – Get Rating) and Purplebricks Group (OTCMKTS:PRPPF – Get Rating) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, risk, earnings, analyst recommendations and profitability. Volatility and Risk H. Lundbeck A/S has a beta […]
Rgenta Therapeutics has snagged $60 million in a Series A round participated by Highlight Capital, while IDG Capital has led Taichu Biotech‘s $58m Series A.